Skip to main content

Research

The latest research in type 1 diabetes, type 2 diabetes, prediabetes, and beyond. Here you’ll find information on experimental therapies, new data and results, and scientific findings.

While the benefits of exercise are well known, a recent study presented at the annual Scientific Sessions of the American Heart Association in November provided some...
As health care spending becomes an increasing concern, the cost associated with chronic disease – particularly diabetes – is becoming an important issue to consider. A...
Beta cell regeneration, dedifferentiation, redifferentiation, isolation, and encapsulation: this article reviews some of the leading curative research, profiling...
In April 2006, Dr. Louis Monnier and colleagues published an article in JAMA that challenged the conventional wisdom about diabetes management and complications.
What will it take to get an artificial pancreas approved? It seems that the path ahead may now be a bit clearer…
In mid-April, the popular press was full of reports on an exciting new paper published in the Journal of the American Medical Society on a stem-cell treatment for type 1...
The Journal of the American Medical Association (JAMA) published a controversial meta-analysis suggesting that people who are overweight (a body mass index [BMI] of 25-...
Weight expert Dr. David Cummings discusses why bariatric surgery goes far beyond weight loss for type 2 diabetes.
The artificial pancreas is coming – will it be connected to an iPhone? What we learned at Children with Diabetes - Focus on Technology.
A study in the Journal of the American Medical Association ( JAMA ) found that patients with type 2 diabetes who had been taking the GLP-1 agonists Bydureon (exenatide...
Can more type 2 therapies be used for type 1 diabetes?
Part 1 of our interview with the Helmsley Charitable Trust’s David Panzirer and T1D Exchange's Dana Ball.
Kelly’s transformative experience wearing an artificial pancreas for five days.
On November 1, Dr. Ed Damiano presented results from the Beacon Hill study and Summer Camp study of the bionic pancreas at Carb DM ’s Second Anniversary. For more...
On April 9, Lilly and T1D Exchange announced a five-year research collaboration on projects designed to improve the health and wellbeing of people with type 1 diabetes...
In May, Lexicon announced its results of LX4211, an SGLT-1/SGLT-2 inhibitor. The phase 2 trial finished its open-label, pioneer section, which showed a decrease in...
Halozyme announced recently that Yale researchers have started a 20-patient artificial pancreas study (which is still recruiting) that will test the ability of...
On April 24, Hyperion Therapeutics announced that it would acquire Andromeda Biotech. Andromeda is focused on the development of a first-in-class immune therapy for new...
TrialNet is bringing their services online, making it easier for people to be screened for type 1 diabetes. Family members of those with type 1 diabetes can answer an...
On November 4, JDRF announced a partnership with Pfizer’s Centers for Therapeutic Innovation (CTI) to support what they call promising diabetes research in collaboration...

Pages